Event

Delegates will learn and hear from three internationally respected researchers who will deliver clinically focused yet practical presentations on Nasal High Flow (NHF) therapy with F&P Optiflow™and F&P AIRVO™. At the end of this symposium delegates will be able to: > Identify the current evidence for Nasal High Flow (NHF) therapy > Evaluate the emerging and clinically significant applications for NHF therapy > Direct evidence-based process change regarding the use of NHF therapy